A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update

• Published in: BMC infectious diseases Vol. 21; no. 1; pp. 906 - 7
• Main Authors: Mohammadi, Faezeh, Badri, Milad, Safari, Shapoor, Hemmat, Nima
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 03.09.2021; BioMed Central; BMC
• Subjects: Biopsy; Case Report; Case reports; Case studies; Complications and side effects; Coronaviruses; Corticoids; Corticosteroids; COVID-19; Debridement; Diabetes; Diabetes Mellitus; Disease; Dosage and administration; Fungal infections; Fungi; Health services; Humans; Hyphae; Infections; Infectious diseases; Invasive Fungal Infections - diagnosis; Invasive Fungal Infections - drug therapy; Laboratories; Literature reviews; Lungs; Male; Methylprednisolone; Middle Aged; Mortality; Mucormycosis; Mucormycosis - diagnosis; Mucormycosis - drug therapy; Mycology; Oxygen saturation; Patient outcomes; Patients; Physicians; Polymerase chain reaction; Respiratory distress syndrome; Rhizopus oryzae; Risk factors; SARS-CoV-2; Septum; Sinuses; Steroids; Viral diseases; Iran; United Kingdom > UK; COVID-19; Mucormycosis; Rhizopus oryzae

COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based...